- Amwell Announces Reverse Stock Split
- Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors
- Amwell Co-Founder Roy Schoenberg Becomes Executive Vice Chairman of the Board
- Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference
- AMWELL ANNOUNCES RESULTS FOR FIRST QUARTER 2024
- Amwell Releases 2024 Corporate Responsibility Report
- Amwell to Participate in Upcoming Investor Conference
- Amwell® to Report First Quarter 2024 Operating Results May 1
- Amwell Receives Continued Listing Standard Notice From NYSE
- Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.295 |
---|---|
High | 0.3168 |
Low | 0.295 |
Bid | 0.291 |
Offer | 0.2963 |
Previous close | 0.295 |
Average volume | 7.04m |
---|---|
Shares outstanding | 299.12m |
Free float | 240.67m |
P/E (TTM) | -- |
Market cap | 89.74m USD |
EPS (TTM) | -1.22 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 22:00 BST.
More ▼